Featured Research

from universities, journals, and other organizations

Obesity Drugs Not A Quick Fix For Achieving Weight Loss

Date:
July 27, 1999
Source:
Washington University In St. Louis
Summary:
Researchers today understand more about the problem of obesity than at any other time in history, but the number of obese Americans continues to increase. Although the search for effective treatments has intensified, only a small number of obese people lose their excess weight and keep it off.

by Jim Dryden

Researchers today understand more about the problem of obesity than at any other time in history, but the number of obese Americans continues to increase. Although the search for effective treatments has intensified, only a small number of obese people lose their excess weight and keep it off.

Once thought of as little more than "letting yourself go," obesity now is treated as an illness that has genetic, behavioral, environmental and medical components. Researchers continue to learn about the balance between caloric intake and energy expenditure, but they admit that many aspects of obesity are poorly understood and that therapies often are unsuccessful in the long term.

Changes in lifestyle are the cornerstone of obesity therapy. Eating less and increasing physical activity usually help obese patients lose weight, and losing as little as 5 percent to 10 percent of total body weight can improve a patient's medical outlook by lowering cholesterol and blood pressure and by ameliorating diabetes and other conditions exacerbated by obesity.

Maintaining lifestyle changes and keeping weight off for life is a difficult proposition. But researchers at Washington University School of Medicine in St. Louis say drug therapy can help improve long-term results for properly selected patients. However, Samuel Klein, M.D., professor of medicine and director of the Center for Human Nutrition at Washington University's School of Medicine, argues in a June 1999 editorial in the American Journal of Clinical Nutrition that drug therapy may be most useful for maintaining rather than achieving weight loss.

Social pressure

Many patients think of medication as a first treatment. Most have tried all kinds of diets, and most have lost weight. But when the diet ends, the weight tends to come back. And unlike some patients with other chronic diseases, those with obesity are very aware of their problem. "If you have hypertension, no one may know it except you and your physician," Klein says. "If you have obesity, everybody knows it, so there is additional social pressure to lose weight. This pressure drives many patients to look to drugs as a possible quick fix."

The Food and Drug Administration has approved nine obesity drugs to date. Eight work by altering metabolism in the brain to suppress appetite and keep patients from feeling the need to eat. The ninth and newest, called Xenical (orlistat), prevents absorption of fat from the gastrointestinal tract. When compared with study patients who were given inactive placebos, about twice as many patients treated with Xenical had lost 10 percent or more of their body weight at the end of one year.

Klein says, however, that patients at Washington University's Weight Management Center are not considered for drug therapy until after they have participated in the program for at least six weeks. By that time, many already have lost significant amounts of weight. "Most patients would like a pill to make their disease go away, but no such pill exists for obesity, and our program steers patients to lifestyle changes instead," Klein says. "By the time our patients have been in our program for six weeks and are eligible for weight-loss drugs, many have made so much progress by changing their diet and increasing their physical activity that they no longer are interested in obesity drugs."

Maintaining lifestyle changes

But problems can develop when a program ends. Even in the most reputable programs, obese patients who lose 10 percent, 20 percent or even 30 percent of their body weight eventually are left without group meetings and other medical and psychological support services. Maintaining lifestyle changes gets more difficult then.

"During the first several months of the program, we provide behavior therapy, diet education and exercise training, and that is usually very effective in getting patients to lose weight. But maintaining the weight loss is much more difficult," Klein says. "Therefore, we consider drug therapy as a tool to help patients maintain their weight loss or to continue their weight loss if their body weight has stopped at an undesirable level."

But while Klein sees a role for obesity drugs, he says there is little research to show they will be effective over many years. Because most are relatively new, studies have looked at time periods of one to two years. "But obesity is a chronic condition that requires long-term therapy, and a trial that demonstrates efficacy for a year or two doesn't prove the drug will still be effective five, 10 or even 20 years later," he says.

Just as patients with hypertension, diabetes or other chronic illnesses can require therapy for a lifetime, Klein believes obese patients need to maintain their lifestyle changes forever and obesity drugs may help. But just as the first generation hypertension and diabetes drugs were not as effective as the medications developed later, Klein says future obesity drugs will be more effective. "The newer approaches will involve a better understanding of chemicals in our brain that regulate food intake as well as chemicals involved in burning up calories," he says.

In spite of the many molecular and behavioral contributors to obesity, a simple formula still applies, Klein stresses. To lose weight, people must burn more calories than they take in, a strategy that is made more difficult by sedentary jobs, elevators, cars and the easy availability of fast food. He says a person who sits at a computer all day, takes the elevator to the snack machine a few times each day and drives to the pizza place or hamburger joint for dinner and maybe a few beers is a good candidate for weight problems. Unless those behaviors change, he says, all the diet drugs in the world won't make that person thin.

###

Note: For more information, please refer to Klein S. "The War Against Obesity: Attacking a New Front," American Journal of Clinical Nutrition, 69(6), 1061-1063, June 1999.


Story Source:

The above story is based on materials provided by Washington University In St. Louis. Note: Materials may be edited for content and length.


Cite This Page:

Washington University In St. Louis. "Obesity Drugs Not A Quick Fix For Achieving Weight Loss." ScienceDaily. ScienceDaily, 27 July 1999. <www.sciencedaily.com/releases/1999/07/990727073325.htm>.
Washington University In St. Louis. (1999, July 27). Obesity Drugs Not A Quick Fix For Achieving Weight Loss. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/07/990727073325.htm
Washington University In St. Louis. "Obesity Drugs Not A Quick Fix For Achieving Weight Loss." ScienceDaily. www.sciencedaily.com/releases/1999/07/990727073325.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins